Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-22

Clinical Trial Update: A Study to Compare the Amount of Meloxicam in the Blood When it is Taken as Capsules or as Tablets [Phase 1]

View source ↗

Summary

A Phase 1 trial comparing blood levels of meloxicam after taking capsules versus tablets in healthy volunteers; results completed with data posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MELOXICAM (MELOXICAM)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2019-11-22